4.5 Article

Ventricular features as reliable differentiators between bvFTD and other dementias

Journal

NEUROIMAGE-CLINICAL
Volume 33, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.nicl.2022.102947

Keywords

Frontotemporal dementia; Dementia; Brain imaging; Lateral ventricles - Classification

Categories

Funding

  1. Canadian Consortium on Neurodegeneration in Aging
  2. Alzheimer Society Research Program (ASRP) postdoctoral award
  3. Canadian Institutes of Health Research
  4. Alzheimer Society of Canada
  5. Sanofi
  6. Women's Brain Health Initiative
  7. Canadian Institutes of Health Research [MOP-111169]
  8. Fonds de Research SanteQuebec Pfizer Innovation fund
  9. NSERC CREATE grant [4140438 -2012]
  10. Famille Louise Andre Charron
  11. Fonds de Recherche du Quebec Sante (FRQS)
  12. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  13. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  14. National Institute on Aging
  15. National Institute of Biomedical Imaging and Bioengineering
  16. AbbVie
  17. Alzheimer's Association
  18. Alzheimer's Drug Discovery Foundation
  19. Araclon Biotech
  20. BioClinica, Inc.
  21. Biogen
  22. Bristol-Myers Squibb Company
  23. CereSpir, Inc.
  24. Cogstate
  25. Eisai Inc.
  26. Elan Pharmaceuticals, Inc.
  27. Eli Lilly and Company
  28. EuroImmun
  29. F. Hoffmann-La Roche Ltd
  30. Genentech, Inc.
  31. Fujirebio
  32. GE Healthcare
  33. IXICO Ltd.
  34. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  35. Johnson & Johnson Pharmaceutical Research & Development LLC.
  36. Lumosity
  37. Lundbeck
  38. Merck Co., Inc.
  39. Meso Scale Diagnostics, LLC.
  40. NeuroRx Research
  41. Neurotrack Technologies
  42. Novartis Pharmaceuticals Corporation
  43. Pfizer Inc.
  44. Piramal Imaging
  45. Servier
  46. Takeda Pharmaceutical Company
  47. Transition Therapeutics
  48. Frontotemporal Lobar Degeneration Neuroimaging Initiative (National Institutes of Health Grant) [R01 AG032306]

Ask authors/readers for more resources

This study used an automated tool to analyze lateral ventricles and found that ventricular features, particularly the antero-posterior ratio (APR), may be reliable and easy-to-implement markers for the diagnosis of behavioral variant frontotemporal dementia (bvFTD). Differentiating bvFTD from other dementia cohorts achieved a high accuracy using either other ventricular features or just the APR feature alone.
Introduction: Lateral ventricles are reliable and sensitive indicators of brain atrophy and disease progression in behavioral variant frontotemporal dementia (bvFTD). We aimed to investigate whether an automated tool using ventricular features could improve diagnostic accuracy in bvFTD across neurodegenerative diseases. Methods: Using 678 subjects 69 bvFTD, 38 semantic variant, 37 primary non-fluent aphasia, 218 amyloid + mild cognitive impairment, 74 amyloid + Alzheimer's Dementia and 242 normal controls- with a total of 2750 timepoints, lateral ventricles were segmented and differences in ventricular features were assessed between bvFTD, normal controls and other dementia cohorts. Results: Ventricular antero-posterior ratio (APR) was the only feature that was significantly different and increased faster in bvFTD compared to all other cohorts. We achieved a 10-fold cross-validation accuracy of 80% (77% sensitivity, 82% specificity) in differentiating bvFTD from all other cohorts with other ventricular features (i.e., total ventricular volume and left-right lateral ventricle ratios), and 76% accuracy using only the single APR feature. Discussion: Ventricular features, particularly the APR, might be reliable and easy-to-implement markers for bvFTD diagnosis. We have made our ventricle feature estimation and bvFTD diagnostic tool publicly available, allowing application of our model in other studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available